PNC Financial Services Group’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | – | Sell |
-17,500
| Closed | -$650K | – | 4640 |
|
|
2015
Q4 | $650K | Sell |
17,500
-3,571
| -17% | -$133K | ﹤0.01% | 1399 |
|
|
2015
Q3 | $1.03M | Buy |
21,071
+5,971
| +40% | +$291K | ﹤0.01% | 1214 |
|
|
2015
Q2 | $1.04M | Hold |
15,100
| – | – | ﹤0.01% | 1255 |
|
|
2015
Q1 | $540K | Buy |
15,100
+15,087
| +116,054% | +$540K | ﹤0.01% | 1592 |
|
|
2014
Q4 | $0 | Sell |
13
-9,487
| -100% | – | ﹤0.01% | 4320 |
|
|
2014
Q3 | $146K | Hold |
9,500
| – | – | ﹤0.01% | 2181 |
|
|
2014
Q2 | $258K | Hold |
9,500
| – | – | ﹤0.01% | 1778 |
|
|
2014
Q1 | $254K | Hold |
9,500
| – | – | ﹤0.01% | 1766 |
|
|
2013
Q4 | $234K | Buy |
9,500
+850
| +10% | +$20.9K | ﹤0.01% | 1794 |
|
|
2013
Q3 | $278K | Buy |
+8,650
| New | +$278K | ﹤0.01% | 1684 |
|